journalEvidence level BIndependent
Evidence pageEfficacy and safety of autologous adipose tissue-derived stem cell therapy for children with refractory Crohn's complex fistula: a Phase IV clinical study
Annals of Surgical Treatment and Research (Cho YJ et al.; via PubMed Central)
accessed Nov 11, 2026Updated Nov 11, 2026
Original source
https://pmc.ncbi.nlm.nih.gov/articles/PMC8255577/
pmc.ncbi.nlm.nih.gov
Verification
| Verification | Independent of the subject |
| Evidence level | B · Peer-reviewed or professional body |
| Independent | Independent of the subject |
| Source | journal |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (5)
FactAdipose-derived Stem Cell: Example post-approval study (Korea) = Phase IV study of autologous adipose-derived stem cells (Anterogen) in children with refractory Crohn's complex fistulaAnswer크론병 치루에 쓰는 지방줄기세포 치료제는 어떤 근거가 있나요?Answer韓国で承認されている脂肪由来幹細胞製品(Queencell・Cupistem)は、どんな治療に使われるのですか?Answer孩子患克罗恩病,肛瘘反复不愈,有没有脂肪干细胞用于儿童的研究?Answerما مستوى الادلة على استخدام الخلايا الجذعية الدهنية في ناسور داء Crohn، ولماذا سحب ترخيص Alofisel؟